Discovery of Activation-Induced Cytidine Deaminase, the Engraver of Antibody Memory

Advances in Immunology

Volumn 94, Issue , 2007, Pages 1-36

  Muramatsu, Masamichi ^a   Nagaoka, Hitoshi ^a   Shinkura, Reiko ^a   Begum, Nasim A ^a   Honjo, Tasuku ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ACTIVATION INDUCED CYTIDINE DEAMINASE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; APOLIPOPROTEIN C1; CD40 LIGAND; CYCLINE; CYCLOHEXIMIDE; CYTIDINE DEAMINASE; DOUBLE STRANDED DNA; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PEANUT AGGLUTININ; PUROMYCIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; URACIL DNA GLYCOSIDASE;

CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL NUCLEUS; CELL SURFACE; CHROMOSOME 12; CHROMOSOME 6; CLASS SWITCH RECOMBINATION; CRYSTAL STRUCTURE; CULTURE MEDIUM; CYTOPLASM; DEAMINATION; DIMERIZATION; DNA BINDING; DNA CLEAVAGE; DNA LIBRARY; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; EVOLUTIONARY HOMOLOGY; EXCISION REPAIR; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; GENE LOCUS; HUMAN; HYBRIDOMA; HYPERIMMUNOGLOBULINEMIA G SYNDROME; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; LYMPHOID HYPERPLASIA; MUTATION; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA EDITING; RNA TRANSLATION; SHEEP ERYTHROCYTE; SIGNAL TRANSDUCTION; SOMATIC HYPERMUTATION; SOUTHERN BLOTTING; STOP CODON; T CELL LYMPHOMA;

ANIMALS; ANTIBODIES; B-LYMPHOCYTES; CYTIDINE DEAMINASE; DNA CLEAVAGE; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; RNA EDITING; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; URACIL-DNA GLYCOSIDASE;

EID: 34249801641     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(06)94001-2     Document Type: Review

References (118)

1. Akbari M., Otterlei M., Pena-Diaz J., Aas P.A., Kavli B., Liabakk N.B., Hagen L., Imai K., Durandy A., Slupphaug G., and Krokan H.E. Repair of U/G and U/A in DNA by UNG2-associated repair complexes takes place predominantly by short-patch repair both in proliferating and growth-arrested cells. Nucleic Acids Res. 32 (2004) 5486-5498
2. Allen R.C., Armitage R.J., Conley M.E., Rosenblatt H., Jenkins N.A., Copeland N.G., Bedell M.A., Edelhoff S., Disteche C.M., Simoneaux D.K., Fanslow W.C., Belmont J., et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259 (1993) 990-993
3. Aravind L., and Koonin E.V. The α/β fold uracil DNA glycosylases: A common origin with diverse fates. Genome Biol. 1 (2000) RESEARCH0007
4. Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., Bajorath J., Grosmaire L.S., Stenkamp R., Neubauer M., Roberts R.L., Noelle R.J., et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72 (1993) 291-300
5. Bachl J., Carlson C., Gray-Schopfer V., Dessing M., and Olsson C. Increased transcription levels induce higher mutation rates in a hypermutating cell line. J. Immunol. 166 (2001) 5051-5057
6. Barreto V., Reina-San-Martin B., Ramiro A.R., McBride K.M., and Nussenzweig M.C. C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol. Cell 12 (2003) 501-508
7. Basu U., Chaudhuri J., Alpert C., Dutt S., Ranganath S., Li G., Schrum J.P., Manis J.P., and Alt F.W. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 438 (2005) 508-511
8. Begum N.A., Kinoshita K., Kakazu N., Muramatsu M., Nagaoka H., Shinkura R., Biniszkiewicz D., Boyer L.A., Jaenisch R., and Honjo T. Uracil DNA glycosylase activity is dispensable for immunoglobulin class switch. Science 305 (2004) 1160-1163
9. Begum N.A., Kinoshita K., Muramatsu M., Nagaoka H., Shinkura R., and Honjo T. De novo protein synthesis is required for activation-induced cytidine deaminase-dependent DNA cleavage in immunoglobulin class switch recombination. Proc. Natl. Acad. Sci. USA 101 (2004) 13003-13007
10. Begum N.A., Izumi N., Nishikori M., Nagaoka H., Shinkura R., and Honjo T. Requirement of non-canonical activity of uracil DNA glycosylase for class switch reccombination. J. Biol. Chem. 283 (2006) 732-742
11. BouHamdan M., Xue Y., Baudat Y., Hu B., Sire J., Pomerantz R.J., and Duan L.X. Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins. J. Biol. Chem. 273 (1998) 8009-8016
12. Bransteitter R., Pham P., Scharff M.D., and Goodman M.F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA 100 (2003) 4102-4107
13. Bransteitter R., Pham P., Calabrese P., and Goodman M.F. Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase. J. Biol. Chem. 279 (2004) 51612-51621
14. Brar S.S., Watson M., and Diaz M. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J. Biol. Chem. 279 (2004) 26395-26401
15. Bross L., Muramatsu M., Kinoshita K., Honjo T., and Jacobs H. DNA double-strand breaks: Prior to but not sufficient in targeting hypermutation. J. Exp. Med. 195 (2002) 1187-1192
16. Casellas R., Nussenzweig A., Wuerffel R., Pelanda R., Reichlin A., Suh H., Qin X.F., Besmer E., Kenter A., Rajewsky K., and Nussenzweig M.C. Ku80 is required for immunoglobulin isotype switching. EMBO J. 17 (1998) 2404-2411
17. Catalan N., Selz F., Imai K., Revy P., Fischer A., and Durandy A. The block in immunoglobulin class switch recombination caused by activation-induced cytidine deaminase deficiency occurs prior to the generation of DNA double strand breaks in switch μ region. J. Immunol. 171 (2003) 2504-2509
18. Chaudhuri J., Tian M., Khuong C., Chua K., Pinaud E., and Alt F.W. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422 (2003) 726-730
19. Chaudhuri J., Khuong C., and Alt F.W. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 430 (2004) 992-998
20. Chen C.Y., Mosbaugh D.W., and Bennett S.E. Mutations at arginine 276 transform human uracil-DNA glycosylase into a single-stranded DNA-specific uracil-DNA glycosylase. DNA Repair (Amst.) 4 (2005) 793-805
21. Chen R., Le Rouzic E., Kearney J.A., Mansky L.M., and Benichou S. Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. J. Biol. Chem. 279 (2004) 28419-28425
22. Chester A., Somasekaram A., Tzimina M., Jarmuz A., Gisbourne J., O'Keefe R., Scott J., and Navaratnam N. The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay. EMBO J. 22 (2003) 3971-3982
23. Conticello S.G., Thomas C.J., Petersen-Mahrt S.K., and Neuberger M.S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol. 22 (2005) 367-377
24. Di Noia J., and Neuberger M.S. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419 (2002) 43-48
25. Di Noia J.M., and Neuberger M.S. Immunoglobulin gene conversion in chicken DT40 cells largely proceeds through an abasic site intermediate generated by excision of the uracil produced by AID-mediated deoxycytidine deamination. Eur. J. Immunol. 34 (2004) 504-508
26. Di Noia J.M., Rada C., and Neuberger M.S. SMUG1 is able to excise uracil from immunoglobulin genes: Insight into mutation versus repair. EMBO J. 25 (2006) 585-595
27. Dickerson S.K., Market E., Besmer E., and Papavasiliou F.N. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 197 (2003) 1291-1296
28. DiSanto J.P., Bonnefoy J.Y., Gauchat J.F., Fischer A., and de Saint Basile G. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361 (1993) 541-543
29. Doi T., Kinoshita K., Ikegawa M., Muramatsu M., and Honjo T. De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination. Proc. Natl. Acad. Sci. USA 100 (2003) 2634-2638
30. Dudley D.D., Manis J.P., Zarrin A.A., Kaylor L., Tian M., and Alt F.W. Internal IgH class switch region deletions are position-independent and enhanced by AID expression. Proc. Natl. Acad. Sci. USA 99 (2002) 9984-9989
31. Durandy A., Schiff C., Bonnefoy J.Y., Forveille M., Rousset F., Mazzei G., Milili M., and Fischer A. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome. Eur. J. Immunol. 23 (1993) 2294-2299
32. Eto T., Kinoshita K., Yoshikawa K., Muramatsu M., and Honjo T. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells. Proc. Natl. Acad. Sci. USA 100 (2003) 12895-12898
33. Facchetti F., Appiani C., Salvi L., Levy J., and Notarangelo L.D. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J. Immunol. 154 (1995) 6624-6633
34. Fagarasan S., Muramatsu M., Suzuki K., Nagaoka H., Hiai H., and Honjo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298 (2002) 1424-1427
35. Faili A., Aoufouchi S., Gueranger Q., Zober C., Leon A., Bertocci B., Weill J.C., and Reynaud C.A. AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nat. Immunol. 3 (2002) 815-821
36. Fu Y.X., Huang G., Wang Y., and Chaplin D.D. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α-dependent fashion. J. Exp. Med. 187 (1998) 1009-1018
37. Fugmann S.D., Rush J.S., and Schatz D.G. Non-redundancy of cytidine deaminases in class switch recombination. Eur. J. Immunol. 34 (2004) 844-849
38. Fukita Y., Jacobs H., and Rajewsky K. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity 9 (1998) 105-114
39. Fuleihan R., Ramesh N., and Geha R.S. Role of CD40-CD40-ligand interaction in Ig-isotype switching. Curr. Opin. Immunol. 5 (1993) 963-967
40. Hamada H., Hiroi T., Nishiyama Y., Takahashi H., Masunaga Y., Hachimura S., Kaminogawa S., Takahashi-Iwanaga H., Iwanaga T., Kiyono H., Yamamoto H., and Ishikawa H. Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J. Immunol. 168 (2002) 57-64
41. Harris R.S., Petersen-Mahrt S.K., and Neuberger M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10 (2002) 1247-1253
42. Honjo T., Kinoshita K., and Muramatsu M. Molecular mechanism of class switch recombination: Linkage with somatic hypermutation. Annu. Rev. Immunol. 20 (2002) 165-196
43. Honjo T., Nagaoka H., Shinkura R., and Muramatsu M. AID to overcome the limitations of genomic information. Nat. Immunol. 6 (2005) 655-661
44. Imai K., Catalan N., Plebani A., Marodi L., Sanal O., Kumaki S., Nagendran V., Wood P., Glastre C., Sarrot-Reynauld F., Hermine O., Forveille M., et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J. Clin. Invest. 112 (2003) 136-142
45. Ito S., Nagaoka H., Shinkura R., Begum N., Muramatsu M., Nakata M., and Honjo T. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl. Acad. Sci. USA 101 (2004) 1975-1980
46. Kavli B., Slupphaug G., Mol C.D., Arvai A.S., Peterson S.B., Tainer J.A., and Krokan H.E. Excision of cytosine and thymine from DNA by mutants of human uracil-DNA glycosylase. EMBO J. 15 (1996) 3442-3447
47. Kavli B., Andersen S., Otterlei M., Liabakk N.B., Imai K., Fischer A., Durandy A., Krokan H.E., and Slupphaug G. B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil. J. Exp. Med. 201 (2005) 2011-2021
48. Kinoshita K., Tashiro J., Tomita S., Lee C.G., and Honjo T. Target specificity of immunoglobulin class switch recombination is not determined by nucleotide sequences of S regions. Immunity 9 (1998) 849-858
49. Ko R., and Bennett S.E. Physical and functional interaction of human nuclear uracil-DNA glycosylase with proliferating cell nuclear antigen. DNA Repair (Amst.) 4 (2005) 1421-1431
50. Kong Q., and Maizels N. DNA breaks in hypermutating immunoglobulin genes: Evidence for a break-and-repair pathway of somatic hypermutation. Genetics 158 (2001) 369-378
51. Korthauer U., Graf D., Mages H.W., Briere F., Padayachee M., Malcolm S., Ugazio A.G., Notarangelo L.D., Levinsky R.J., and Kroczek R.A. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361 (1993) 539-541
52. Kotani A., Okazaki I.M., Muramatsu M., Kinoshita K., Begum N.A., Nakajima T., Saito H., and Honjo T. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression. Proc. Natl. Acad. Sci. USA 102 (2005) 4506-4511
53. Le Hir M., Bluethmann H., Kosco-Vilbois M.H., Muller M., di Padova F., Moore M., Ryffel B., and Eugster H.P. Tumor necrosis factor receptor-1 signaling is required for differentiation of follicular dendritic cells, germinal center formation, and full antibody responses. J. Inflamm. 47 (1995) 76-80
54. MacDuff D.A., Neuberger M.S., and Harris R.S. MDM2 can interact with the C-terminus of AID but it is inessential for antibody diversification in DT40 B cells. Mol. Immunol. 43 (2006) 1099-1108
55. Mackay F., Majeau G.R., Lawton P., Hochman P.S., and Browning J.L. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27 (1997) 2033-2042
56. Manis J.P., Gu Y., Lansford R., Sonoda E., Ferrini R., Davidson L., Rajewsky K., and Alt F.W. Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J. Exp. Med. 187 (1998) 2081-2089
57. Manis J.P., Dudley D., Kaylor L., and Alt F.W. IgH class switch recombination to IgG1 in DNA-PKcs-deficient B cells. Immunity 16 (2002) 607-617
58. Mansky L.M., Preveral S., Selig L., Benarous R., and Benichou S. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate. J. Virol. 74 (2000) 7039-7047
59. Martin A., and Scharff M.D. Somatic hypermutation of the AID transgene in B and non-B cells. Proc. Natl. Acad. Sci. USA 99 (2002) 12304-12308
60. Martin A., Bardwell P.D., Woo C.J., Fan M., Shulman M.J., and Scharff M.D. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415 (2002) 802-806
61. Matsumoto M., Lo S.F., Carruthers C.J., Min J., Mariathasan S., Huang G., Plas D.R., Martin S.M., Geha R.S., Nahm M.H., and Chaplin D.D. Affinity maturation without germinal centres in lymphotoxin-α-deficient mice. Nature 382 (1996) 426-462
62. McBride K.M., Barreto V., Ramiro A.R., Stavropoulos P., and Nussenzweig M.C. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J. Exp. Med. 199 (2004) 1235-1244
63. Mehta A., Kinter M.T., Sherman N.E., and Driscoll D.M. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol. Cell. Biol. 20 (2000) 1846-1854
64. Mer G., Edwards A.M., and Chazin W.J. 1H, 15N and 13C resonance assignments for the C-terminal protein interaction region of the 32 kDa subunit of human replication protein A. J. Biomol. NMR 17 (2000) 179-180
65. Mol C.D., Arvai A.S., Slupphaug G., Kavli B., Alseth I., Krokan H.E., and Tainer J.A. Crystal structure and mutational analysis of human uracil-DNA glycosylase: Structural basis for specificity and catalysis. Cell 80 (1995) 869-878
66. Morgan H.D., Dean W., Coker H.A., Reik W., and Petersen-Mahrt S.K. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: Implications for epigenetic reprogramming. J. Biol. Chem. 279 (2004) 52353-52360
67. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., and Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274 (1999) 18470-18476
68. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
69. Muto A., Tashiro S., Nakajima O., Hoshino H., Takahashi S., Sakoda E., Ikebe D., Yamamoto M., and Igarashi K. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 429 (2004) 566-571
70. Muto T., Muramatsu M., Taniwaki M., Kinoshita K., and Honjo T. Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics 68 (2000) 85-88
71. Nagaoka H., Muramatsu M., Yamamura N., Kinoshita K., and Honjo T. Activation-induced deaminase (AID)-directed hypermutation in the immunoglobulin Sμ region: Implication of AID involvement in a common step of class switch recombination and somatic hypermutation. J. Exp. Med. 195 (2002) 529-534
72. Nagaoka H., Ito S., Muramatsu M., Nakata M., and Honjo T. DNA cleavage in immunoglobulin somatic hypermutation depends on de novo protein synthesis but not on uracil DNA glycosylase. Proc. Natl. Acad. Sci. USA 102 (2005) 2022-2027
73. Nagelhus T.A., Haug T., Singh K.K., Keshav K.F., Skorpen F., Otterlei M., Bharati S., Lindmo T., Benichou S., Benarous R., and Krokan H.E. A sequence in the N-terminal region of human uracil-DNA glycosylase with homology to XPA interacts with the C-terminal part of the 34-kDa subunit of replication protein A. J. Biol. Chem. 272 (1997) 6561-6566
74. + cells. Int. Immunol. 8 (1996) 193-201
75. Nambu Y., Sugai M., Gonda H., Lee C.G., Katakai T., Agata Y., Yokota Y., and Shimizu A. Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 302 (2003) 2137-2140
76. Navaratnam N., Fujino T., Bayliss J., Jarmuz A., How A., Richardson N., Somasekaram A., Bhattacharya S., Carter C., and Scott J. Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition. J. Mol. Biol. 275 (1998) 695-714
77. Neuberger M.S., and Milstein C. Somatic hypermutation. Curr. Opin. Immunol. 7 (1995) 248-254
78. Neuberger M.S., Harris R.S., Di Noia J., and Petersen-Mahrt S.K. Immunity through DNA deamination. Trends Biochem. Sci. 28 (2003) 305-312
79. Odegard V.H., Kim S.T., Anderson S.M., Shlomchik M.J., and Schatz D.G. Histone modifications associated with somatic hypermutation. Immunity 23 (2005) 101-110
80. Okazaki I.M., Kinoshita K., Muramatsu M., Yoshikawa K., and Honjo T. The AID enzyme induces class switch recombination in fibroblasts. Nature 416 (2002) 340-345
81. Okazaki I.M., Hiai H., Kakazu N., Yamada S., Muramatsu M., Kinoshita K., and Honjo T. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197 (2003) 1173-1181
82. Otterlei M., Haug T., Nagelhus T.A., Slupphaug G., Lindmo T., and Krokan H.E. Nuclear and mitochondrial splice forms of human uracil-DNA glycosylase contain a complex nuclear localisation signal and a strong classical mitochondrial localisation signal, respectively. Nucleic Acids Res. 26 (1998) 4611-4617
83. Otterlei M., Warbrick E., Nagelhus T.A., Haug T., Slupphaug G., Akbari M., Aas P.A., Steinsbekk K., Bakke O., and Krokan H.E. Post-replicative base excision repair in replication foci. EMBO J. 18 (1999) 3834-3844
84. Pan-Hammarstrom Q., Jones A.M., Lahdesmaki A., Zhou W., Gatti R.A., Hammarstrom L., Gennery A.R., and Ehrenstein M.R. Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells. J. Exp. Med. 201 (2005) 189-194
85. Papavasiliou F.N., and Schatz D.G. The activation-induced deaminase functions in a postcleavage step of the somatic hypermutation process. J. Exp. Med. 195 (2002) 1193-1198
86. Parikh S.S., Mol C.D., Slupphaug G., Bharati S., Krokan H.E., and Tainer J.A. Base excision repair initiation revealed by crystal structures and binding kinetics of human uracil-DNA glycosylase with DNA. EMBO J. 17 (1998) 5214-5226
87. Pearl L.H. Structure and function in the uracil-DNA glycosylase superfamily. Mutat. Res. 460 (2000) 165-181
88. Peters A., and Storb U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4 (1996) 57-65
89. Petersen S., Casellas R., Reina-San-Martin B., Chen H.T., Difilippantonio M.J., Wilson P.C., Hanitsch L., Celeste A., Muramatsu M., Pilch D.R., Redon C., Ried T., et al. AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching. Nature 414 (2001) 660-665
90. Petersen-Mahrt S.K., Harris R.S., and Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418 (2002) 99-103
91. Pham P., Bransteitter R., Petruska J., and Goodman M.F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424 (2003) 103-107
92. Priet S., Gros N., Navarro J.M., Boretto J., Canard B., Querat G., and Sire J. HIV-1-associated uracil DNA glycosylase activity controls dUTP misincorporation in viral DNA and is essential to the HIV-1 life cycle. Mol. Cell 17 (2005) 479-490
93. Rada C., Williams G.T., Nilsen H., Barnes D.E., Lindahl T., and Neuberger M.S. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12 (2002) 1748-1755
94. Rada C., Di Noia J.M., and Neuberger M.S. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell 16 (2004) 163-171
95. Ramiro A.R., Jankovic M., Eisenreich T., Difilippantonio S., Chen-Kiang S., Muramatsu M., Honjo T., Nussenzweig A., and Nussenzweig M.C. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118 (2004) 431-438
96. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., Tezcan I., Ersoy F., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102 (2000) 565-575
97. Rosner A.J., and Keren D.F. Demonstration of M cells in the specialized follicle-associated epithelium overlying isolated lymphoid follicles in the gut. J. Leukoc. Biol. 35 (1984) 397-404
98. Rush J.S., Fugmann S.D., and Schatz D.G. Staggered AID-dependent DNA double strand breaks are the predominant DNA lesions targeted to Sμ in Ig class switch recombination. Int. Immunol. 16 (2004) 549-557
99. Ryffel B., Di Padova F., Schreier M.H., Le Hir M., Eugster H.P., and Quesniaux V.F. Lack of type 2 T cell-independent B cell responses and defect in isotype switching in TNF-lymphotoxin α-deficient mice. J. Immunol. 158 (1997) 2126-2133
100. Savva R., and Pearl L.H. Nucleotide mimicry in the crystal structure of the uracil-DNA glycosylase-uracil glycosylase inhibitor protein complex. Nat. Struct. Biol. 2 (1995) 752-757
101. Schrader C.E., Linehan E.K., Mochegova S.N., Woodland R.T., and Stavnezer J. Inducible DNA breaks in Ig S regions are dependent on AID and UNG. J. Exp. Med. 202 (2005) 561-568
102. Selig L., Benichou S., Rogel M.E., Wu L.I., Vodicka M.A., Sire J., Benarous R., and Emerman M. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest. J. Virol. 71 (1997) 4842-4846
103. Shinkura R., Ito S., Begum N.A., Nagaoka H., Muramatsu M., Kinoshita K., Sakakibara Y., Hijikata H., and Honjo T. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat. Immunol. 5 (2004) 707-712
104. Slupphaug G., Mol C.D., Kavli B., Arvai A.S., Krokan H.E., and Tainer J.A. A nucleotide-flipping mechanism from the structure of human uracil-DNA glycosylase bound to DNA. Nature 384 (1996) 82-92
105. Stavnezer J. Immunoglobulin class switching. Curr. Opin. Immunol. 8 (1996) 199-205
106. Studebaker A.W., Ariza M.E., and Williams M.V. Depletion of uracil-DNA glycosylase activity is associated with decreased cell proliferation. Biochem. Biophys. Res. Commun. 334 (2005) 509-515
107. Ta V.T., Nagaoka H., Catalan N., Durandy A., Fischer A., Imai K., Nonoyama S., Tashiro J., Ikegawa M., Ito S., Kinoshita K., Muramatsu M., et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat. Immunol. 4 (2003) 843-848
108. Teng B., Burant C.F., and Davidson N.O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260 (1993) 1816-1819
109. Teng B.B., Ochsner S., Zhang Q., Soman K.V., Lau P.P., and Chan L. Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization. J. Lipid Res. 40 (1999) 623-635
110. Tonegawa S. Somatic generation of antibody diversity. Nature 302 (1983) 575-581
111. Wang J., Shinkura R., Muramatsu M., Nagaoka H., Kinoshita K., and Honjo T. Identification of a specific domain required for dimerization of activation-induced cytidine deaminase. J. Biol. Chem. 281 (2006) 19115-19123
112. Wang Z., and Mosbaugh D.W. Uracil-DNA glycosylase inhibitor gene of bacteriophage PBS2 encodes a binding protein specific for uracil-DNA glycosylase. J. Biol. Chem. 264 (1989) 1163-1171
113. Woo C.J., Martin A., and Scharff M.D. Induction of somatic hypermutation is associated with modifications in immunoglobulin variable region chromatin. Immunity 19 (2003) 479-489
114. Wu X., Geraldes P., Platt J.L., and Cascalho M. The double-edged sword of activation-induced cytidine deaminase. J. Immunol. 174 (2005) 934-941
115. Xiao G., Tordova M., Jagadeesh J., Drohat A.C., Stivers J.T., and Gilliland G.L. Crystal structure of Escherichia coli uracil DNA glycosylase and its complexes with uracil and glycerol: Structure and glycosylase mechanism revisited. Proteins 35 (1999) 13-24
116. Yoshikawa K., Okazaki I.M., Eto T., Kinoshita K., Muramatsu M., Nagaoka H., and Honjo T. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296 (2002) 2033-2036
117. Yu K., Huang F.T., and Lieber M.R. DNA substrate length and surrounding sequence affect the activation-induced deaminase activity at cytidine. J. Biol. Chem. 279 (2004) 6496-6500
118. Zhu Y., Nonoyama S., Morio T., Muramatsu M., Honjo T., and Mizutani S. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. J. Med. Dent. Sci. 50 (2003) 41-46